A Phase III study of Genentech and Roche’s drug Avastin with paclitaxel chemotherapy in first- line metastatic breast cancer proved to be more effective than chemotherapy alone.
Avastin Plus Chemotherapy Shows Improvement
Genentech and Roche announced that an interim analysis of a Phase III study of Avastin (bevacizumab) plus paclitaxel chemotherapy…
Phase III Avastin Study Results
Genentech and Roche announced that an interim analysis of a Phase III study of Avastin plus paclitaxel and carboplatin chemotherapies in first-line non-squamous, non-small cell lung cancer…